| Literature DB >> 33554965 |
Faith M Harris1, Karoline A Meagher2, Maggie Zhong1, Benjamin J Daniel3, Mark Eckersdorff1, Jesse A Green1, Vera Voronina1, Chunguang Guo1, Andre Limnander4, Lynn E Macdonald1.
Abstract
Extensive studies have characterized the development and differentiation of murine B cells in secondary lymphoid organs. Antibodies secreted by B cells have been isolated and developed into well-established therapeutics. Validation of murine B cell development, in the context of autoimmune prone mice, or in mice with modified immune systems, is a crucial component of developing or testing therapeutic agents in mice and is an appropriate use of flow cytometry. Well established B cell flow cytometric parameters can be used to evaluate B cell development in the murine peritoneum, bone marrow, and spleen, but a number of best practices must be adhered to. In addition, flow cytometric analysis of B cell compartments should also complement additional readouts of B cell development. Data generated using this technique can further our understanding of wild type, autoimmune prone mouse models as well as humanized mice that can be used to generate antibody or antibody-like molecules as therapeutics.Entities:
Year: 2021 PMID: 33554965 DOI: 10.3791/61565
Source DB: PubMed Journal: J Vis Exp ISSN: 1940-087X Impact factor: 1.355